FORTREA HOLDINGS INC. (FTRE) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 17.10M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 1.04B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 2.71B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $17.10M | $1.04B | (m) | (m) | $2.71B | (m) |
| 2026-03-31 | (m) | (m) | $10.90M | $1.04B | (m) | (m) | $2.68B | (m) |
| 2025-12-31 | (m) | (m) | $4.80M | $1.05B | (m) | (m) | $2.72B | (m) |
| 2025-09-30 | (m) | (m) | $74.50M | $1.05B | (m) | (m) | $2.74B | (m) |
| 2025-06-30 | (m) | (m) | $74.80M | $1.10B | (m) | (m) | $2.84B | (m) |
| 2025-03-31 | (m) | (m) | $163.80M | $1.05B | (m) | (m) | $3.12B | (m) |
| 2024-12-31 | (m) | (m) | $74.80M | $1.05B | (m) | (m) | $3.58B | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | $1.12B | (m) | (m) | $3.66B | (m) |
| 2024-06-30 | (m) | (m) | $0.00 | $1.12B | (m) | (m) | $3.57B | (m) |
| 2024-03-31 | (m) | (m) | $55.00M | $1.56B | (m) | (m) | $4.24B | (m) |
| 2023-12-31 | (m) | (m) | $26.10M | $1.57B | (m) | (m) | $4.36B | (m) |
| 2023-09-30 | (m) | (m) | $26.10M | $1.57B | (m) | (m) | $4.32B | (m) |
| 2023-06-30 | (m) | (m) | $26.10M | $1.58B | (m) | (m) | $4.36B | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $4.29B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |